# Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy

> **NIH NIH F31** · STANFORD UNIVERSITY · 2021 · $13,537

## Abstract

PROJECT SUMMARY/ABSTRACT
No change from original proposed activities.

## Key facts

- **NIH application ID:** 10372839
- **Project number:** 3F31CA239510-02S1
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Jacqueline Carozza
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $13,537
- **Award type:** 3
- **Project period:** 2021-04-01 → 2021-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10372839

## Citation

> US National Institutes of Health, RePORTER application 10372839, Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy (3F31CA239510-02S1). Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/grant/nih/10372839. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*